A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
for Recurrent Head and Neck Squamous Cell Carcinoma
8 locations incl. Duarte
Sponsor: Rakuten Medical, Inc.
Sex: All·Age: 18+
Code: NCT06699212·Phase 3·Recruiting